Nottingham University Hospitals Selects Nervecentre for EPR
In early February, Nottingham University Hospitals NHS Trust chose Nervecentre’s next-generation EPR to advance its digital capabilities and enhance patient care, in what the company described as a transformative deal. NUH selected Nervecentre following a competitive procurement process on the Health Systems Support (HSS) Framework Agreement, solidifying their long-standing partnership with the company and positioning Nervecentre at the core of the trust’s digital transformation strategy. Nottingham is the fourth trust in the East Midlands to commit to Nervecentre’s EPR in just over three months. Northampton General Hospital also selected Nervecentre as its EPR supplier in December.
County Durham and Darlington Go Live with Health Call’s Patient Portal
In the first week of February, County Durham and Darlington NHS Foundation Trust launched their Patient Engagement Portal in partnership with NHS-owned digital health company Health Call. The trust was able to rapidly implement MyHealthCall PEP, a technology that connects patients with their care organizations through the NHS App. The integration was made possible by Health Call’s Platform Integration Engine. MyHealthCall PEP is now live and will initially allow selected patients to manage outpatient appointments digitally, with the intention to make this available to all relevant/appropriate patients. County Durham and Darlington NHS Foundation Trust is the first organization in the county to leverage Health Call’s Platform Integration Engine, designed to expedite PEP implementation by seamlessly integrating it with current and legacy systems for swift deployment.
Northern Care Alliance NHS Trust Completes Sectra Go-Live
The Northern Care Alliance NHS Trust’s Oldham site went live with Sectra’s digital pathology solution, enhancing multi-disciplinary team meetings and collaboration. Seven laboratories across the Greater Manchester Pathology Network will transition to the enterprise imaging network from Sectra, following in the footsteps of Stockport NHS Foundation Trust, which was the first to deploy the technology earlier in 2023. The network’s existing agreement with the medical imaging technology provider will see more pathologists and biomedical scientists in Greater Manchester move to high-quality digital images in place of microscopes. Acute trusts in the region are also using the same system to view and analyze radiology imaging.
NHS Somerset ICB Awards Contract to Black Pear
NHS Somerset Integrated Care Board announced that Black Pear Software Ltd has been awarded a five plus two-year contract as the Somerset Integrated Digital e-Record+ (SIDeR+) technology partner. The first SIDeR contract with Black Pear commenced in 2018 and is due to end in April 2024. With Black Pear, the SIDeR now exceeds 30,000 uses per month since going live in 2020 from over 2,200 users across health and care organizations in Somerset and over the border. Over 42,000 care plans are hosted on SIDeR that can be created, read, or updated by any appropriate member of staff involved in that person’s care. SIDeR+ will launch in April of this year and will build on the existing SIDeR service, delivering an on-demand shared care record and a suite of persisted shared care forms to support direct care.
University Hospitals of Leicester Goes Live with AI-reviewed Chest X-rays
University Hospitals of Leicester NHS Trust recently implemented an AI-powered chest x-ray solution as part of the multi-NHS site LungIMPACT research study. The trust is using Qure.ai’s qXR AI, integrated into the Radiology Information System from Magentus, to review around 100-150 GP-referred x-rays every day. This system will identify and triage the presence of potential lung abnormalities and provide immediate reporting to clinicians, enabling them to make next-stage decisions on CT referrals or treatment planning. The LungIMPACT study is a collaboration between Qure.ai, UK academia, and NHS hospitals, to gather real-world evidence of AI-assisted diagnoses of lung cancer.
